摘要
目的探讨慢性肺源性心脏病患者血管内皮生长因子水平变化及其临床意义。方法收集正常对照组36例、慢性肺源性心脏病患者52例,并测定血清血管内皮生长因子含量。结果两组间血清VEGF含量存在显著差异。结论 VEGF可能参与了慢性肺源性心脏病的进程。
Objective To investigate the level and clinical significance of serum vascular endothelial growth factor( VEGF) in chronic pulmonary heart disease patients. Methods Collected 36 healthy people,52 chronic pulmonary heart disease patients and tested the level of serum vascular endothelial growth factor. Results There were significant difference in vascular endothelial growth factor level between 2 groups. Conclusion VEGF probably took part in the progression of chronic pulmonary heart disease.
引文
[1]云春梅,赵小娟,李晓玲.阻塞性睡眠呼吸暂停低通气综合征合并高血压患者血清白介素6、血管内皮生长因子水平的研究[J].中国临床医学,2011,18(4):430-432.
[2]Acarregui MJ,Penisten ST,Goss KL,et al.Vascular endothelial growth factor gene expression in human fetal lung in vitro[J].Am J Respir Cell Mol Biol,1999,20(1):14-23.
[3]Libby P,Ridker PM,Hansson GK.Progress and challenges in translating the biology of antherosclerosis[J].Nature,2011,473(7347):317-325.
[4]Christou H,Yoshida A,Arthur V,et al.Increased vascular endothelial growth factor production in the lungs of rats with hypoxiainduced pulmonary hypertension[J].Am J Respir Cell Mol Biol,1998,18(6):768-776.
[5]Hiroshi Kanazawa.Role of vascular endothelial growth factor in the pathogenesis of chronic obstructive pulmonary disease[J].Med Sci Monit,2007,13(11):189-195.
[6]Wang Z,Castresana MR,Newman WH.Reative oxygen and NFkappa B in VEGF-induced migration of human vascular smooth muscle cells[J].Biochem Biophys Res Commun,2001,285(3):669-674.